Loading...
XNAS
POCI
Market cap49mUSD
Oct 08, Last price  
4.67USD
1D
3.21%
1Q
-6.33%
Jan 2017
690.68%
Name

Precision Optics Corporation Inc

Chart & performance

D1W1MN
XNAS:POCI chart
P/E
—
P/S
1.62
EPS
—
Div yield, %
—
Shrs. gr., 5y
14.02%
Rev. gr., 5y
24.19%
Revenues
32m
+65.16%
2,477,4692,902,2193,528,5103,094,4372,245,1372,152,3962,519,7433,651,1813,912,0603,916,7023,154,5474,038,0486,804,1699,923,35510,674,90715,678,24821,044,46719,104,35019,091,26931,531,765
Net income
-4m
L-37.20%
-2,889,829-1,623,354-992,135-660,882-1,052,613960,972-1,787,680-1,160,638-1,178,793-1,034,765-1,006,457-351,390-614,871-1,426,150-102,835-928,416-144,613-2,951,377-5,780,246-3,629,891
CFO
-2m
L-56.30%
-3,334,918-696,868-532,65452,283-413,525-1,585,515-1,293,392-886,031-773,793-876,298-667,434100,657-1,031,693-592,49246,550-933,371-81,090-2,683,012-3,547,400-1,550,219

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Precision Optics Corporation, Inc. focuses on the engineering, manufacturing, and commercialization of sophisticated optical and lighting systems, alongside their related constituent parts. The company primarily serves markets within the United States and the European Economic Area. Its product portfolio includes medical instruments like endoscopes and endocouplers, in addition to tailored imaging and illumination solutions such as high-precision miniature lenses, micro medical cameras, and specialized 3D endoscopes. These offerings are designed for minimally invasive surgical procedures, utilized by healthcare facilities and medical professionals. Furthermore, Precision Optics supplies various components and assemblies for both industrial and defense sectors. The firm distributes its medical products to other medical device manufacturers. Established in 1982, Precision Optics Corporation, Inc. is headquartered in Gardner, Massachusetts.

Key people

Joseph N. Forkey
President, Chief Executive Officer, Treasurer, Director · since 2014
Andrew J. Miclot
Director · since 2016
Kenneth S. Schwartz
Director · since 2014
Chairman of the Board, Director · since 2014
Richard B. Miles
Independent Director · since 2005
IPO date
Jan 16, 1992
Employees
76
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑062025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT